Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0064 | 0.0261 | 0.0584 |
Schistosoma mansoni | nephrin | 0.0038 | 0.0092 | 0.0329 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0037 | 0.0057 |
Brugia malayi | bone morphogenetic protein type 1 receptor | 0.0403 | 0.2437 | 0.5472 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0064 | 0.0261 | 0.0562 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0023 | 0 | 0.5 |
Echinococcus granulosus | TGF beta receptor type 1 | 0.0386 | 0.233 | 0.524 |
Echinococcus multilocularis | tyrosine protein kinase | 0.0716 | 0.4445 | 0.4444 |
Echinococcus granulosus | activin receptor type | 0.0403 | 0.2437 | 0.5482 |
Echinococcus granulosus | tyrosine protein kinase | 0.0716 | 0.4445 | 1 |
Echinococcus multilocularis | activin receptor type | 0.0403 | 0.2437 | 0.2436 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0032 | 0.0055 | 0.0119 |
Brugia malayi | plexin A | 0.0043 | 0.0125 | 0.0256 |
Brugia malayi | Protein kinase domain containing protein | 0.0716 | 0.4445 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0037 | 0.008 |
Echinococcus multilocularis | roundabout 2 | 0.0038 | 0.0092 | 0.009 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0029 | 0.0037 | 0.0057 |
Onchocerca volvulus | 0.0055 | 0.0203 | 0.9847 | |
Brugia malayi | EGF-like domain containing protein | 0.0056 | 0.0206 | 0.0438 |
Schistosoma mansoni | cell adhesion molecule | 0.0029 | 0.0037 | 0.0103 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0031 | 0.0048 | 0.0103 |
Loa Loa (eye worm) | TK protein kinase | 0.0716 | 0.4445 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0083 | 0.0183 |
Echinococcus multilocularis | tyrosine protein kinase transmembrane receptor | 0.0025 | 0.0012 | 0.001 |
Echinococcus granulosus | TGF-beta receptor type-1 | 0.0386 | 0.233 | 0.524 |
Echinococcus granulosus | plexin a4 | 0.0043 | 0.0125 | 0.0279 |
Schistosoma mansoni | ephrin receptor | 0.0031 | 0.0048 | 0.0146 |
Onchocerca volvulus | Slit protein homolog | 0.0056 | 0.0206 | 1 |
Echinococcus granulosus | tyrosine protein kinase transmembrane receptor | 0.0025 | 0.0012 | 0.0023 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0029 | 0.0037 | 0.0057 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0031 | 0.0048 | 0.0046 |
Loa Loa (eye worm) | hypothetical protein | 0.0699 | 0.4337 | 0.9757 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0206 | 0.0461 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0037 | 0.008 |
Echinococcus granulosus | roundabout 2 | 0.0038 | 0.0092 | 0.0203 |
Loa Loa (eye worm) | TKL/STKR/TYPE1 protein kinase | 0.0403 | 0.2437 | 0.5482 |
Onchocerca volvulus | 0.0036 | 0.0083 | 0.3641 | |
Loa Loa (eye worm) | TK protein kinase | 0.0025 | 0.0012 | 0.0023 |
Echinococcus multilocularis | slit 2 protein | 0.0056 | 0.0206 | 0.0205 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0037 | 0.008 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0025 | 0.0012 | 0.0023 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0032 | 0.0055 | 0.0096 |
Schistosoma mansoni | plexin | 0.0036 | 0.0083 | 0.0291 |
Echinococcus multilocularis | TGF beta receptor type 1 | 0.0386 | 0.233 | 0.2328 |
Echinococcus multilocularis | plexin a4 | 0.0043 | 0.0125 | 0.0124 |
Schistosoma mansoni | protein kinase | 0.0386 | 0.233 | 0.9556 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0023 | 0 | 0.5 |
Brugia malayi | Plexin repeat family protein | 0.0036 | 0.0083 | 0.0159 |
Echinococcus granulosus | slit 2 protein | 0.0056 | 0.0206 | 0.0461 |
Schistosoma mansoni | protein kinase | 0.0403 | 0.2437 | 1 |
Loa Loa (eye worm) | plexin A | 0.0043 | 0.0125 | 0.0279 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.